2m 2m 2m 2m 2m 2m 2m
TG Therap (TGTX)
NASDAQ
$53.87-$0.02 (-0.05%)
Price as of Sep 11, 2026 7:30 PM EDT- $8.2BMarket Cap
- 67.57%1-Year Change
- BiotechnologyIndustry
TG Therap (TGTX)
$53.87-$0.02 (-0.05%)
TGTX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $53.89 | ||
Change | -$1.50 (-2.71%) | ||
Open | $55.71 | ||
High | $56.26 | ||
Low | $53.47 | ||
Previous Close | $55.39 | ||
Volume | 1,368,582 | ||
30-Day Average Volume | 1,837,994 | ||
1-Week Change | -3.74% | ||
1-Month Change | 8.00% | ||
1-Year Change | 67.57% | ||
3-Year Change | 407.44% | ||
5-Year Change | 80.90% | ||
Fundamentals | |||
Shares Outstanding | 153.1M | ||
Total Assets | $1.6B | ||
Market Cap | $8.2B | ||
Enterprise Value | $8.5B | ||
Period: QTR TTM FY | |||
Revenue | $235.8M | ||
Net Income | $7.8M | ||
Free Cash Flow | $39.0M | ||
EBIT | $10.2M | ||
EBITDA | $10.3M | ||
Net Working Capital | $877.2M | ||
EPS | $0.05 | ||
Enterprise Value/EBITDA | 827 | ||
Enterprise Value/Revenue | 36 | ||
P/B | 14 | ||
P/E | 1,078 | ||
PEG | -18 | ||
Price/Free Cash Flow | 212 | ||
Price/Operating Cash Flow | 210 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 56.25 | ||
Last Split Date | 04/30/2012 | ||
Earnings & Revenue